{Reference Type}: Editorial
{Title}: The Biden Administration's Push to Lower Drug Prices Through March-In Rights.
{Author}: Aaron DG;Anderson JJ;
{Journal}: JAMA
{Volume}: 332
{Issue}: 6
{Year}: 2024 08 13
{Factor}: 157.335
{DOI}: 10.1001/jama.2024.12327
{Abstract}: This Viewpoint explores a 2023 Biden administration proposal for US agencies to use their march-in rights and the impact this proposed framework could have on drug prices.